GENELUX Corp

For the period ended Dec 31, 2025. Filed Mar 19, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 19, 2026

GNLX$1.95-5.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets as of December 31, 2025 and 2024

Balance Sheets

(in thousands, except for share amounts)

	December 31,
	2025	2024
ASSETS
Current assets:
Cash, cash equivalents and restricted cash	$5,333	$8,565
Marketable securities	9,262	22,330
Prepaid expenses and other current assets	535	653
Total current assets	15,130	31,548
Property and equipment, net	2,170	1,316
Right of use assets	1,583	1,760
Other assets	144	92
Total Assets	$19,027	$34,716
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$4,358	$5,570
Accrued payroll and payroll taxes	1,440	1,004
Lease liabilities, current portion	427	329
Total current liabilities	6,225	6,903
Lease liabilities, net of current portion	1,258	1,539
Total liabilities	7,483	8,442
Commitments and contingencies (Note 10)	-	-
Stockholders’ equity:
Common stock, par value $0.001, 200,000,000 shares authorized; 38,139,144 and 34,728,140 shares issued and outstanding	38	35
Treasury stock, 433,333 shares, at cost	(433)	(433)
Additional paid-in capital	295,468	278,001
Accumulated other comprehensive income	9	64
Accumulated deficit	(283,538)	(251,393)
Total stockholders’ equity	11,544	26,274
Total Liabilities and Stockholders’ Equity	$19,027	$34,716

The accompanying notes are an integral part of these financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.